Donald S. Fredrickson
Donald S. Fredrickson | |
---|---|
11th Director of the National Institutes of Health | |
In office July 1, 1975 – June 30, 1981 | |
President | |
Preceded by | Robert Stone |
Succeeded by | James Wyngaarden |
Personal details | |
Born | Donald Sharp Fredrickson August 8, 1924 Canon City, Colorado |
Died | June 7, 2002 Bethesda, Maryland | (aged 77)
Nationality | American |
Alma mater | University of Michigan |
Scientific career | |
Fields | Lipid metabolism |
Institutions | |
Donald Sharp "Don" Fredrickson (August 8, 1924 – June 7, 2002) was an American medical researcher, principally of the lipid and cholesterol metabolism, and director of National Institutes of Health and subsequently the Howard Hughes Medical Institute.[1]
Biography
Fredrickson was born in
Between 1949 and 1952 he worked as a resident and subsequently as a fellow in
Lipid research
In 1953 he took up a post at the
In 1967 Fredrickson co-authored the paper that described the classification of lipoprotein abnormalities in five types, depending on the pattern of lipoprotein
Textbooks
From 1960 he worked, with
Directorships
Apart from his work in research, Fredrickson was involved in the management of the NHI from an early stage. He was clinical director from 1960 onward and from 1966 general director of NHI. In 1974 he left the NHI (then already the National Heart and Lung Institute) to head the
One of the main issues that occupied him was the controversy over research involving recombinant DNA. Already in 1973 there had been scientists urging a ban on such research for environmental reasons. Fredrickson released a guideline that restricted release of genetically modified organisms into the environment, and called into existence a body that would advise on these matters and had to approve any NIH research involving recombinant DNA technology. Fredrickson is credited with restoring confidence in this form of research.[1] A second controversy involved congressional control over the NIH in general. Some feel that Fredrickson's decision to resign from his position in 1981 was fuelled by these controversies.[1] The recombinant DNA controversy was the subject of a book published by Fredrickson in 2001.[5]
After 1981 Fredrickson was scholar-in-residence at the
Later years
Fredrickson returned to the NIH, resuming work on lipid diseases and writing for the
He was a member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Philosophical Society.[7][8][9]
He was personal physician to Hassan II of Morocco, and had a close personal friendship with the king until the latter's death in 1999.[1]
He was found dead, face-down, in his
His papers are held at the National Library of Medicine in Bethesda, Maryland.[10]
References
- ^ ISBN 0-309-09579-4. Fulltext. Reprinted from Proc Am Phil Soc 2004;148(3):382-393. PDF Archived September 27, 2007, at the Wayback Machine.
- ^ Fredrickson DS, Altrocchi PH, Avioli LV, Goodman DS, Goodman HC. Tangier disease. Ann Intern Med 1961;55:1016-1031.
- PMID 5333081.
- ^ Stanbury JB, Wyngaarden JB, Fredrickson DS (Eds). The Metabolic Basis of Inherited Disease. New York, Toronto, and London: McGraw-Hill, 1960.
- ISBN 1-55581-222-8.
- PMID 10535983.
- ^ "Donald S. Fredrickson". www.nasonline.org. Retrieved 2022-05-17.
- ^ "Donald Sharp Fredrickson". American Academy of Arts & Sciences. Retrieved 2022-05-17.
- ^ "APS Member History". search.amphilsoc.org. Retrieved 2022-05-17.
- ^ "Donald S. Fredrickson Papers 1910-2002 (bulk 1960-1999)". National Library of Medicine.
External links
- The Donald S. Fredrickson Papers, Profiles in Science, National Library of Medicine
- Donald S. Fredrickson Papers (1910-2002) National Library of Medicine finding aid